Optimizing Cellular Imaging with AI, ML, and DL to Accelerate Drug Discovery

Recently, cellular assays and imaging technologies have seen remarkable advancements in throughput capacity. These improvements are highly beneficial for researchers aiming to produce robust and reliable data, as they allow for the rapid collection of large volumes of information without compromising data quality. However, the resulting datasets are often vast and complex, posing a significant challenge in terms of timely and efficient evaluation. This issue is particularly critical in the field of drug discovery, where actionable insights and fast turnaround times are essential for progress. To address this challenge, artificial intelligence-based technologies are increasingly being integrated into imaging analysis workflows. Among these, machine learning and deep learning have emerged as powerful tools, enabling automated and scalable analysis of cellular images. These approaches not only accelerate data interpretation but also enhance accuracy and reproducibility. As a result, AI is becoming an indispensable component in modern drug discovery pipelines. In this context, we explore the growing role of artificial intelligence in cellular image analysis and its potential to transform how researchers process and utilize imaging data in pharmaceutical and biomedical research. This article explores Optimizing Cellular Imaging with AI, ML, and DL to Accelerate Drug Discovery and describes its various dimensions.

کلیدواژه ها:

Cellular imaging ، Artificial intelligence ، Machine learning ، Deep learning